Drug Trial Radar · NCT02993302
Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients
Last checked: Nov 20, 2026Latest source record: Mar 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Jul 2014
Primary completion
Mar 2015
Study completion Mar 2015
Sponsor
- Lead sponsor
- Dr Cipto Mangunkusumo General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Universitas Indonesia
- First posted
- Dec 15, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Maturity level of dendritic cells (DC) plays a pivotal role in initiating and regulating autoimmunity. In Graves' disease (GD), DCs have more active immune responses than those in healthy subjects. Our previous study demonstrated immunoregulatory effects of in vitro 1,25-D3 on maturation of DC in GD patients. This study aims to evaluate the effect of oral 1α-D3 on DC maturation in GD patients.
Conditions
- Graves Disease
Interventions
1α-D3Drug
patients were given PTU and 1α-D3
PlacebosDrug
patients were given PTU and placebos
Primary outcomes
What the sponsor says the trial is designed to measure.
- CD80 LevelTime frame: 1 year
- CD206 LevelTime frame: 1 year
- IL-12/IL-10 RatioTime frame: 1 year
- fT4 LevelsTime frame: 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.